Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Renal Biomarkers Market – Insights

A biomarker can be defined as a biological characteristic of an organism that is measured as an indicator of normal biological process. Renal biomarkers are an important tool in diagnosis of various kidney diseases and detection of acute and chronic kidney injuries. An ideal renal biomarker must be able to detect kidney disorders at the initial stage.

The global renal biomarkers market is estimated to account for US$ 1,094.5 Mn in terms of value in 2019 and is expected to reach US$ 1,894.2 Mn by the end of 2027.

Global Renal Biomarkers Market: Drivers

Increasing prevalence of chronic kidney diseases is expected to propel growth of the global renal biomarkers market over the forecast period. For instance, according to European Renal Association – European Dialysis and Transplant Association’s data in 2018, over 850 million people worldwide have some form of kidney disease.

Moreover, increasing rate of progression of chronic kidney disease in children is also expected to aid in growth of the market. For instance, according to the study, ‘Risk Factors and Rate of Progression of CKD in Children’, published in June 2019 in Kidney International Reports, 38% children experienced progression of chronic kidney disease within 2 years of follow-up.

North America region held dominant position in the global renal biomarkers market in 2018, accounting for 32.5% share in terms of value, followed by Europe.

Renal Biomarkers  | Coherent Market Insights

Global Renal Biomarkers Market: Restraints

Low sensitivity and specificity of biomarkers is expected to hinder growth of the global renal biomarkers market. For instance, some renal biomarkers such as L-18 are more specific although are not very sensitive, while other biomarkers such as osteopontin are highly sensitive though they are not specific.

Moreover, use of unreliable, imperfect gold standards is also expected to limit growth of the market. Serum creatinine, although having low sensitivity and specificity, is used as gold standard. Serum creatinine does not distinguish whether the reason for rise in levels is due to renal injury or other non-renal causes such as hemodynamic (obstructive uropathy) mediated changes. Moreover, serum creatinine is also not effective in renal recovery and injury.

Global Renal Biomarkers Market: Opportunities 

Players in the market may focus on collaborating with academia in order to identify new biomarkers that will facilitate drug development.

Moreover, R&D in renal biomarkers is also expected to aid in growth of the market. For instance, in February 2020, researchers from NLC India Limited, National Institute of Mental Health and Neurosciences, and Madras Diabetes Research Foundation (MDRF), Chennai, India reported identifying urine based biomarker, Micro albuminuria, for early prediction of diabetic kidney failure.

Renal Biomarkers  | Coherent Market Insights

Functional biomarkers segment in the global renal biomarkers market was valued at US$ 543.6 Mn in 2018 and is expected to reach US$ 1,057.3 Mn by 2027 at a CAGR of 7.6% during the forecast period.

Market Trends/Key Takeaways

Players in the market are focused on developing feline renal biomarkers. For instance, in February 2020, Antech Diagnostics, a part of Mars Petcare, launched Antech SDMA (symmetric dimethylarginine), a feline renal biomarker for early diagnosis, staging and monitoring of chronic kidney disease.

Major players in the market are also focused on conducting studies for R&D of renal biomarkers. For instance, in December 2019, SphingoTec GmbH reported the publication of novel study results of its proprietary kidney function biomarker penKid in BMC Emergency Medicine.

Renal Biomarkers  | Coherent Market Insights

Global Renal Biomarkers Market: Competitive Landscape

Major players operating in the global renal biomarkers market include, Beckman Coulter, Inc., (Danaher Corporation), Thermo Fisher Scientific Inc., Abbott Laboratories, BIOPORTO A/S, Astute Medical, Inc., Randox Laboratories Ltd., and SphingoTec GmbH.

Global Renal Biomarkers Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in January 2020, SphingoTec GmbH launched IB10 sphingotest penKid, a CE-IVD-marked point-of-care test for Proenkephalin, a renal biomarker.

Players in the market are also focused on approval and launch of new biomarkers to expand their product portfolio. For instance, in November 2019, BioPorto A/S announced to supplement its pediatric 510(k) application to the U.S. FDA with additional data for regulatory clearance of The NGAL Test (a biomarker test) for pediatric risk assessment of acute kidney injury.

Chronic kidney disease (CKD) involves gradual loss of functioning of kidneys. The normal function of kidneys are to filter out and excrete wastes, and excess fluids from the blood are excreted through urine. However, when an individual is suffering from chronic kidney disease, kidneys cannot perform their natural function and wastes, fluids, and electrolytes build up in the body in excess amounts. Signs and symptoms of chronic kidney disease are not apparent until kidney function becomes significantly impaired. For this purpose various diagnostic tests are performed which involve use of various tests which asses biomarkers to understand functioning of the kidneys. Increase or decrease in values of these biomarkers indicates dysfunction of kidneys.

Restraints of the Global Renal Biomarkers Market

Factors such as low sensitivity and specificity of biomarkers is expected to hinder growth of the global renal biomarkers market. For instance, some renal biomarkers such as L-18 are more specific although are not very sensitive, while other biomarkers such as osteopontin are highly sensitive though they are not specific.

Key features of the study:

  • This report provides in-depth analysis of the global renal biomarkers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global renal biomarkers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Beckman Coulter, Inc., (Danaher Corporation), Thermo Fisher Scientific Inc., Abbott Laboratories, BIOPORTO A/S, Astute Medical, Inc., Randox Laboratories Ltd., and SphingoTec GmbH.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global renal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Renal Biomarkers Market, By Biomarker Type:
    • Functional Biomarker
      • Serum Creatinine
      • Serum Cystatin C
      • Urine Albumin
    • Up-Regulated Proteins
      • Neutrophil gelatinase-associated lipocalin
      • Kidney injury molecule 1
      • Interleukin 18
    • Others
  • Global Renal Biomarkers Market, By Technique:
    • Enzyme Linked Immunosorbent Assay
    • Particle-Enhanced Turbidimetric Immunoassay
    • Colorimetric Assay
    • Chemiluminescent Enzyme Immunoassay
    • Liquid Chromatography-Mass Spectrometry
  • Global Renal Biomarkers Market, By End User:
    • Diagnostic Labs
    • Outpatient Clinics
    • Research Centers
    • Hospitals
  • Global Renal Biomarkers Market, By Geography:
    • North America
      • By Biomarker Type
        • Functional Biomarker
          • Serum Creatinine
          • Serum Cystatin C
          • Urine Albumin
        • Up-Regulated Proteins
          • Neutrophil gelatinase-associated lipocalin
          • Kidney injury molecule 1
          • Interleukin 18
        • Others
      • By Technique
        • Enzyme Linked Immunosorbent Assay
        • Particle-Enhanced Turbidimetric Immunoassay
        • Colorimetric Assay
        • Chemiluminescent Enzyme Immunoassay
        • Liquid Chromatography-Mass Spectrometry
      • By End User
        • Diagnostic Labs
        • Outpatient Clinics
        • Research Centers
        • Hospitals
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Biomarker Type
        • Functional Biomarker
          • Serum Creatinine
          • Serum Cystatin C
          • Urine Albumin
        • Up-Regulated Proteins
          • Neutrophil gelatinase-associated lipocalin
          • Kidney injury molecule 1
          • Interleukin 18
        • Others
      • By Technique
        • Enzyme Linked Immunosorbent Assay
        • Particle-Enhanced Turbidimetric Immunoassay
        • Colorimetric Assay
        • Chemiluminescent Enzyme Immunoassay
        • Liquid Chromatography-Mass Spectrometry
      • By End User
        • Diagnostic Labs
        • Outpatient Clinics
        • Research Centers
        • Hospitals
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Biomarker Type
        • Functional Biomarker
          • Serum Creatinine
          • Serum Cystatin C
          • Urine Albumin
        • Up-Regulated Proteins
          • Neutrophil gelatinase-associated lipocalin
          • Kidney injury molecule 1
          • Interleukin 18
        • Others
      • By Technique
        • Enzyme Linked Immunosorbent Assay
        • Particle-Enhanced Turbidimetric Immunoassay
        • Colorimetric Assay
        • Chemiluminescent Enzyme Immunoassay
        • Liquid Chromatography-Mass Spectrometry
      • By End User
        • Diagnostic Labs
        • Outpatient Clinics
        • Research Centers
        • Hospitals
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Biomarker Type
        • Functional Biomarker
          • Serum Creatinine
          • Serum Cystatin C
          • Urine Albumin
        • Up-Regulated Proteins
          • Neutrophil gelatinase-associated lipocalin
          • Kidney injury molecule 1
          • Interleukin 18
        • Others
      • By Technique
        • Enzyme Linked Immunosorbent Assay
        • Particle-Enhanced Turbidimetric Immunoassay
        • Colorimetric Assay
        • Chemiluminescent Enzyme Immunoassay
        • Liquid Chromatography-Mass Spectrometry
      • By End User
        • Diagnostic Labs
        • Outpatient Clinics
        • Research Centers
        • Hospitals
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Biomarker Type
        • Functional Biomarker
          • Serum Creatinine
          • Serum Cystatin C
          • Urine Albumin
        • Up-Regulated Proteins
          • Neutrophil gelatinase-associated lipocalin
          • Kidney injury molecule 1
          • Interleukin 18
        • Others
      • By Technique
        • Enzyme Linked Immunosorbent Assay
        • Particle-Enhanced Turbidimetric Immunoassay
        • Colorimetric Assay
        • Chemiluminescent Enzyme Immunoassay
        • Liquid Chromatography-Mass Spectrometry
      • By End User
        • Diagnostic Labs
        • Outpatient Clinics
        • Research Centers
        • Hospitals
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Biomarker Type
        • Functional Biomarker
          • Serum Creatinine
          • Serum Cystatin C
          • Urine Albumin
        • Up-Regulated Proteins
          • Neutrophil gelatinase-associated lipocalin
          • Kidney injury molecule 1
          • Interleukin 18
        • Others
      • By Technique
        • Enzyme Linked Immunosorbent Assay
        • Particle-Enhanced Turbidimetric Immunoassay
        • Colorimetric Assay
        • Chemiluminescent Enzyme Immunoassay
        • Liquid Chromatography-Mass Spectrometry
      • By End User
        • Diagnostic Labs
        • Outpatient Clinics
        • Research Centers
        • Hospitals
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Beckman Coulter, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • BIOPORTO A/S
    • Astute Medical, Inc.
    • Randox Laboratories Ltd.
    • SphingoTec GmbH

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Biomarker Type
      • Market Snippet, By Technique
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
  4. Global Renal Biomarkers Market, By Biomarker Type, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Functional Biomarker
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
        • Serum Creatinine
        • Serum Cystatin C
        • Urine Albumin
    • Up-Regulated Proteins
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
        • Neutrophil gelatinase-associated lipocalin
        • Kidney injury molecule 1
        • Interleukin 18
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Renal Biomarkers Market, By Technique, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Enzyme Linked Immunosorbent Assay
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Particle-Enhanced Turbidimetric Immunoassay
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Colorimetric Assay
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Chemiluminescent Enzyme Immunoassay
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Liquid Chromatography-Mass Spectrometry
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Renal Biomarkers Market, By End User, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Diagnostic Labs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Outpatient Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Research Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Renal Biomarkers Market, By Regions, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Beckman Coulter, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • BIOPORTO A/S
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Astute Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Randox Laboratories Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • SphingoTec GmbH
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 21 figures on “Renal Biomarkers Market – Global forecast to 2027.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner